Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sage Makes Deep Cuts, Axing 53% Of The Workforce, As It Reins In Zulresso

08 Apr 2020

• By Jessica Merrill

Desperate businessmen

Related Content

Sage Plans New Trials And Approval Timeline For Zuranolone

18 Mar 2020

Zulresso Is Sage’s First Step In Postpartum Depression Treatment

20 Mar 2019

Related Companies

Sage Therapeutics, Inc.

Additional Topics

Business Strategies Companies Coronavirus COVID-19 Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.